Development
ADMA Biologics, Inc.
ADMA
$18.54
-$0.42-2.22%
NASDAQ
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -40.65% | 112.45% | 19.27% | -0.43% | 69.36% |
| Total Receivables | 76.85% | 49.83% | 94.51% | 3.47% | -45.74% |
| Inventory | 5.90% | 0.12% | 10.75% | 17.85% | 30.91% |
| Prepaid Expenses | 4.69% | -4.93% | -3.36% | -20.67% | 17.42% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -4.95% | 22.14% | 19.51% | 10.13% | 29.55% |
|
|
|||||
| Total Current Assets | -4.95% | 22.14% | 19.51% | 10.13% | 29.55% |
| Net Property, Plant & Equipment | -7.67% | -4.03% | 1.23% | 12.09% | 18.12% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 0.01% |
| Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 0.01% |
| Total Other Intangibles | -50.74% | -60.00% | -52.18% | -46.15% | -41.40% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -2.10% | 50.76% | 67.44% | 67.00% | 17.27% |
| Total Assets | -5.53% | 16.12% | 15.52% | 10.63% | 26.14% |
|
|
|||||
| Total Accounts Payable | 18.38% | -56.94% | 6.12% | -8.21% | 6.43% |
| Total Accrued Expenses | 29.38% | 67.45% | 105.31% | 52.08% | 42.88% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 15.47% | 36.36% | 68.97% | 46.18% | 53.10% |
| Total Finance Division Other Current Liabilities | 59.52% | 22.58% | -26.24% | -32.40% | 72.42% |
| Total Other Current Liabilities | 59.52% | 22.58% | -26.24% | -32.40% | 72.42% |
| Total Current Liabilities | 26.84% | -5.85% | 49.45% | 16.35% | 29.26% |
|
|
|||||
| Total Current Liabilities | 26.84% | -5.85% | 49.45% | 16.35% | 29.26% |
| Long-Term Debt | -8.57% | 0.47% | 0.36% | 4.25% | 50.56% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -8.64% | -6.31% | -5.97% | 43.71% | 43.44% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 3.10% | -0.09% | 0.00% | -4.96% | 55.19% |
| Total Liabilities | -1.28% | -1.31% | 7.52% | 7.75% | 45.46% |
|
|
|||||
| Common Stock & APIC | 1.82% | 13.05% | 12.85% | 11.77% | 13.86% |
| Retained Earnings | -5.91% | -4.90% | -8.94% | -10.91% | -15.99% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -11.03% | 50.86% | 28.29% | 14.75% | 7.65% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -11.03% | 50.86% | 28.29% | 14.75% | 7.65% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -11.03% | 50.86% | 28.29% | 14.75% | 7.65% |
|
|
|||||